Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash flows from operating activities:
Net income (loss)	$ (97)	$ 2,988
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Impairment losses	208	650
Net losses (gains) on sales of real estate	19	(570)
Deferred income taxes	(129)	(376)
Provision for loan losses, net	646	362
Unrealized premium adjustment	1,229	1,097
Amortization and accretion, net	(102)	(22)
Share-based compensation	119	162
Capitalized loan origination costs	(271)	(170)
Loans funded, held for sale	(20,724)	(17,107)
Proceeds from sale of guaranteed loans	11,969	8,631
Principal collected on loans	499	427
Loan fees remitted, net	(74)	(99)
Change in operating assets and liabilities:
Other assets	(240)	(401)
Borrower advances	2,673	586
Accounts payable and accrued expenses	815	(468)
Other liabilities	81	(49)
Net cash used in operating activities	(3,379)	(4,359)
Cash flows from investing activities:
Loans funded	(19,772)	(6,792)
Principal collected on loans	19,079	13,084
Principal collected on retained interests in transferred assets	82	102
Purchase of furniture and equipment	(11)	(31)
Proceeds from sales of real estate owned, net	678	111
Proceeds from unconsolidated subsidiary		1,373
Release of (investment in) restricted cash and cash equivalents	2,233	(3,093)
Net cash provided by investing activities	2,289	4,754
Cash flows from financing activities:
Proceeds from (repayment of) revolving credit facility, net	(2,800)	1,000
Payment of principal on structured notes payable	(5,264)	(5,156)
Proceeds from issuance of SBIC debentures	4,000	5,000
Proceeds from secured borrowings - government guaranteed loans	8,498	9,733
Payment of principal on secured borrowings - government guaranteed loans	(499)	(427)
Payment of borrowing costs	(97)	(326)
Payment of dividends	(5,058)	(5,072)
Net cash provided by (used in) financing activities	(1,220)	4,752
Net increase (decrease) in cash and cash equivalents	(2,310)	5,147
Cash and cash equivalents, beginning of year	6,502	2,642
Cash and cash equivalents, end of period	$ 4,192	$ 7,789